Cancer News and Research

Latest Cancer News and Research

Machine learning increases the accuracy of anti-cancer drug response predictions

With the advent of pharmacogenomics, machine learning research is well underway to predict the patients' drug response that varies by individual from the algorithms derived from previously collected data on drug responses.

2 Nov 2020

How COVID death counts become the stuff of conspiracy theories

In the waning days of the campaign, President Donald Trump complained repeatedly about how the United States tracks the number of people who have died from COVID-19, claiming, "This country and its reporting systems are just not doing it right."

2 Nov 2020

Study: 1 in 8 patients with cancer have inherited gene mutations

Genetic testing can uncover inherited genetic mutations, and could individualize cancer therapies, improve survival, manage cancer in loved ones and push the boundaries of precision medicine.

2 Nov 2020

Two studies find age as a primary factor in melanoma treatment resistance

Age may cause identical cancer cells with the same mutations to behave differently. In animal and laboratory models of melanoma cells, age was a primary factor in treatment response.

2 Nov 2020

Urbanization leads to a huge decrease in skin bacterial diversity

Urbanization leads to a vast decrease in bacterial diversity and an increase in chemical diversity on the skin, a keynote lecture on the skin microbiome will reveal today at the 29th EADV Congress, EADV Virtual.

2 Nov 2020

Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development

Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company, Servier, announce the extension of a strategic collaboration to deliver industry-proven, innovative characterization and quality control workflows for the simplified analysis of complex therapeutic proteins to advance biopharmaceutical discovery and development.

From Thermo Fisher Scientific Inc. 2 Nov 2020

Genomic sequence of the White House "superspreader" event

Now, a new study revealed the genetic signature of the SARS-CoV-2 that spread in the White House and most likely infected President Trump. The team applied genomic epidemiology to shed light on the origins of the outbreak

2 Nov 2020

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro

Researchers tested 5-amino levulinic acid in vitro in human-derived cells and found it prevents severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Because it is safe and ubiquitous in plants and animals, it could be a potential drug against SARS-CoV-2.

1 Nov 2020

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive.

30 Oct 2020

SARS-CoV-2 virus may target red marrow and prevent the formation of new erythrocytes

Specialists from the Department of Fundamental Medicine of Far Eastern Federal University (FEFU) with Russian and Japanese colleagues have probed into mechanisms of COVID-19 inside-the-body distribution linked to erythrocytes damaging.

30 Oct 2020

First-of-its-kind synthetic DNA vaccine designed against Powassan virus

Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein.

30 Oct 2020

Potential treatment might make tumors more responsive to immunotherapy

Cancer immunotherapies, which empower patients' immune systems to eliminate tumors, are revolutionizing cancer treatment. Many patients respond well to these treatments, sometimes experiencing long-lasting remissions.

30 Oct 2020

Researchers report a novel approach to generate T-cells faster

Adoptively transferred T-cells can prolong survival and sometimes cure patients with advanced solid tumors. While promising, it can take months to generate the necessary T-cells to help these patients. Such slow speed makes this therapy impractical for most patients who need immediate treatment.

30 Oct 2020

Princeton professor selected to receive new award recognizing faculty innovation

Robert Prud'homme, professor of chemical and biological engineering at Princeton University, has been selected to receive the inaugural Dean for Research Award for Distinguished Innovation for the invention of flash nanoprecipitation, a method for creating nanoparticles that promises to improve the delivery of drugs throughout the body.

30 Oct 2020

University of Illinois Urbana-Champaign professor wins $4.5 million for breast cancer research and therapy

University of Illinois Urbana-Champaign Professor of Molecular and Integrative Physiology Erik Nelson has won a $4.5M Era of Hope Scholar Award from the United States Department of Defense (DoD) Breast Cancer Research Program (BCRP).

30 Oct 2020

Cancer patients, clinicians benefit when symptoms are reported using a electronic real-time system

Both cancer patients and their medical teams found it beneficial when patients shared their symptoms in real time using a web- or telephone-based reporting system, according to a national multi-institutional study.

30 Oct 2020

A $200 debit card won’t do much for seniors’ drug costs

If they've been listening to President Donald Trump, seniors may be expecting a $200 debit card in the mail any day now to help them pay for prescription drugs.

30 Oct 2020

Democrats link GOP challengers to Trump’s COVID record, efforts to undo Obamacare

In a tweet to his 78,000 followers Sunday, U.S. Rep. Harley Rouda, a Democrat from Orange County, California, described his Republican opponent Michelle Steel's attendance at an indoor fundraiser without a mask as "sickening."

30 Oct 2020

New project to develop surgical technologies for COVID-19 receives €2.4 million funding

Irish medical tech firm Palliare leads EU H2020 research project with UCD using innovative optical technology for new safer surgery solution.

30 Oct 2020

Researchers design a light-sensitive inhibitor that can control cell division and cell death

Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have designed a light-sensitive inhibitor that can control cell division and cell death - and provides a promising approach for studies of essential cellular processes and the development of novel tumor therapies.

30 Oct 2020

Cancer News and Research

Latest Cancer News and Research

Machine learning increases the accuracy of anti-cancer drug response predictions

How COVID death counts become the stuff of conspiracy theories

Study: 1 in 8 patients with cancer have inherited gene mutations

Two studies find age as a primary factor in melanoma treatment resistance

Urbanization leads to a huge decrease in skin bacterial diversity

Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development

Genomic sequence of the White House "superspreader" event

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

SARS-CoV-2 virus may target red marrow and prevent the formation of new erythrocytes

First-of-its-kind synthetic DNA vaccine designed against Powassan virus

Potential treatment might make tumors more responsive to immunotherapy

Researchers report a novel approach to generate T-cells faster

Princeton professor selected to receive new award recognizing faculty innovation

University of Illinois Urbana-Champaign professor wins $4.5 million for breast cancer research and therapy

Cancer patients, clinicians benefit when symptoms are reported using a electronic real-time system

A $200 debit card won’t do much for seniors’ drug costs

Democrats link GOP challengers to Trump’s COVID record, efforts to undo Obamacare

New project to develop surgical technologies for COVID-19 receives €2.4 million funding

Researchers design a light-sensitive inhibitor that can control cell division and cell death

Industry Focus eBook: Oncology eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook: Oncology eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in